Medibank Private FY16 Earnings Result

MPL.ASX NPAT $418m on EPS of $0.154 and final dividend of $0.065

FY17 outlook is for more of the same, growth will be difficult to achieve and revenue will remain flat, whilst net insurance margins will likely decline or remain flat at best. FY17 EPS $0.15 and DPS $0.12

You're not a member!  Trial today!

Buy on a pullback into the $2.60 $2.75 range. Our algorithm engines will track for the entry alert.

MPL

 

 

Author: Leon Hinde

Leon has been working in the financial services industry for 18 years in management and advisory roles. Leon has extensive experience in general advice and dealings involving securities and derivative financial products.

PS 146 Securities & Derivatives, ADA 1 & 2 accreditation, Responsible Manager Certificate. Leon is authorised to provide financial product advice and deal with respect to the following financial products:

· Deposit Products
· Securities
· Derivatives
· Interest in managed investment schemes; and
· Government debentures, bonds and stocks